AKTX

Akari Therapeutics

10 hedge funds and large institutions have $3.7M invested in Akari Therapeutics in 2019 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 1 reducing their positions, and 3 closing their positions.

Holders
10
Holders Change
+1
Holders Change %
+11.11%
% of All Funds
0.22%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
4
Increased
4
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Market Value Shares Shares
Change
Shares
Change %
HP
1
Hikari Power
Japan
$2.57M 1,500,096 +100,000 +7%
NMC
2
NEA Management Company
Maryland
$773K 452,167
Renaissance Technologies
3
Renaissance Technologies
New York
$232K 135,630 +630 +0.5%
VF
4
Virtu Financial
New York
$53K 31,124 +20,232 +186%
ARTA
5
A.R.T. Advisors
New York
$36K 21,326 +21,326 New
HighTower Advisors
6
HighTower Advisors
Illinois
$25K 15,000 +15,000 New
TC
7
Truvestments Capital
Florida
$6K 3,633 -319 -8%
Bank of America
8
Bank of America
North Carolina
$5K 3,000 +3,000 New
UBS Group
9
UBS Group
Switzerland
$4K 2,481 +2,481 New
Morgan Stanley
10
Morgan Stanley
New York
$2K 1,388 +384 +38%
VC
11
Vivo Capital
California
-345,850 Closed
Deutsche Bank
12
Deutsche Bank
Germany
-132,000 Closed
Parallax Volatility Advisers
13
Parallax Volatility Advisers
California
-7,500 Closed
CFGS
14
Concourse Financial Group Securities
Alabama